)
WW International (WGHTQ) investor relations material
WW International Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Emerged from Chapter 11 bankruptcy on June 24, 2025, implementing a prepackaged reorganization plan that discharged $1.6 billion in prepetition debt, reduced total debt by over 70% (~$1.1 billion), and issued new equity and a $465 million term loan facility.
Adopted fresh start accounting, resulting in a lack of comparability between pre- and post-emergence financials.
Laying foundation for renewed growth in weight management by integrating clinical care, medication access, and behavioral programs, with strategic initiatives including a new Menopause program and executive team expansion.
The company operates as a single segment, focusing on Behavioral and Clinical subscription offerings, with end-of-period subscribers totaling 3.0 million, including 124,000 clinical subscribers (up 59.6% year-over-year).
GLP-1 medications and behavioral support drive superior weight loss outcomes and improved quality of life for members.
Financial highlights
Q3 2025 revenue was $172 million, down 10.8% year-over-year; clinical subscription revenues grew 35.3% to $26 million, while behavioral subscription revenues declined 12.0%.
Adjusted EBITDA was $43 million with a margin of 24.9%; gross margin improved to 72.1%.
Net loss for Q3 2025 was $58 million, with a net loss margin of 33.4% and net loss per share of $5.76.
Ended Q3 with $170 million in cash and cash equivalents, up from $152 million in Q2.
Marketing expenses were $48 million (28.1% of revenue), and capital expenditures were $3 million in Q3.
Outlook and guidance
Full-year 2025 revenue guidance narrowed to $695–$700 million, with adjusted EBITDA guidance raised to $145–$150 million.
Management expects continued disruption and competitive pressures, especially from rapid GLP-1 adoption and new market entrants.
Gross margin expected to decline modestly in Q4 due to seasonal staffing; marketing spend to increase for peak season.
The company believes it has sufficient liquidity to meet obligations for at least 12 months post-report.
Expect Q3 2025 to be the low point for clinical subscribers, with growth anticipated as medication access expands.
Next WW International earnings date
Next WW International earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)